Anticoagulants Flashcards

1
Q

Anistreplase class

A

Thrombolytics activate plasmin

3degree hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anistreplase description

A

purified human plasminogen and bacterial streptokinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alteplase, Reteplase, Tenecteplase class

A

Thrombolytics activate plasmin

3 degree hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alteplase, Reteplase, Tenecteplase description

A

recombinant t-PA
Less selective
Mutant t-PA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alteplase, Reteplase, Tenecteplase mechanism

A

t-PA is a serine protease produced by human endothelial cells that activates plasminogen bound to fibrin (selective)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alteplase, Reteplase, Tenecteplase indication

A

2nd line therapy after angioplasty for treatment of acute MI and ischemic stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Urokinase class

A

Thrombolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Urokinase description

A

Human enzyme synthesized in kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Urokinase mechanism

A

Direct conversion of plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Urokinase indication

A

lysis of PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Streptokinase class

A

Thrombolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Streptokinase mechanism

A

Catalyzes degradation of PF-V and VII in addition to activation of plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Streptokinase description

A

Protein made by beta hemolytic strep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Streptokinase indication

A

Rarely used due to newer drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Warfarin description

A

Coumarin anti-coag

Monitor every 2-4 weeks via PT (INR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Warfarin mechanism

A

Inhibits Vit K epoxide reductase -> can’t gamma carboxylate factors II, VII, IX and X

Factor VII is the first to go -> monitor PT

Can reverse action with Vit K (24 hrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Warfarin indication

A

Hypercoagulable states

Pregnancy category X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Warfarin PK

A

Oral
Several hours to take effect; single dose lasts for 2-5 days
Monitor with INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Warfarin adverse

A

Narrow therapeutic window
Many drug interactions
Hemorrhage

Cutaneous necrosis** ->decreased activity of protein C -> paradoxical hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lepirudin, Bivalirudin, Argatroban description

A

Direct thrombin inhibitors (hirudin from leeches)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lepirudin, Bivalirudin, Argatroban mechanism

A

Direct binding to active site of thrombin

Inhibits thrombin and platelet aggragation

22
Q

Lepirudin, Bivalirudin, Argatroban indication

A

Thrombosis related to HIT

Coronary angioplasty

23
Q

Lepirudin, Bivalirudin, Argatroban PK

A

Parenteral

Monitored with PTT

24
Q

Lepirudin, Bivalirudin, Argatroban adverse

A

No antidote

25
Fondaparinux description
synthetic pentasaccharide
26
Fondaparinux mechanism
*Selective PF-10 inhibitor* -> binds anti-thrombin III allowing it inhibit PF-10 Negligible ATIII activity
27
Fondaparinux indication
Treatment and prevention of DVT
28
Heparin, Enoxaparin, Dalteparin, Tinzaparin description
UFH: mixture of straight chain anionic GAGs LMWH: has higher therapeutic index Pentasaccharide sequence binds ATIII
29
Heparin, Enoxaparin, Dalteparin, Tinzaparin mechanism
UFH: binds to anti-thrombin III -> increased activity -> inhibits thrombin by forming a ternary complex along with factors IX and X LMWH:inhibits factor X, with less of an effect on thrombin than UFH due to lack of ternary complex formation
30
Heparin, Enoxaparin, Dalteparin, Tinzaparin indication
*DOC in pregnancy* DVT PE MI
31
Heparin, Enoxaparin, Dalteparin, Tinzaparin PK
Only given IV, never oral Rapid acting Monitored with PTT Excess heparin is treated with *protamine sulfate*
32
Heparin, Enoxaparin, Dalteparin, Tinzaparin adverse
Bleeding HIT (Type 2): IgG binds to heparin/PF-4 complex -> binding to FcR on platelets ->degranulation and more PF-4 release -> thrombosis and thrombocytopenia Tx. -> disocntinue use and give DTI or fondaparinux****
33
Abciximad mechanism
Irreversible monoclonal Ab
34
Eptifibatide mechanism
Reversible cyclic peptide antagonist
35
Tirofiban mechanism
Non peptide reversible antagonist
36
Abciximab, Eptifibatide, Tirofiban description
GPIIb/IIIa blockers | Platelet aggregation inhibitors
37
Abciximab, Eptifibatide, Tirofiban indication
Acute coronary syndrome Angioplasty give parentally
38
Abciximab, Eptifibatide, Tirofiban adverse
Patients who lack GPIIb/IIIa have Glanzmann's Thrombasthenia
39
Dipyridamole, Cilostazol description
Platelet aggregation inhibitors PDE inhibitor Coronary vasodilation
40
Dipyridamole, Cilostazol mechanism
Increases cAMP | Little effect alone -> coadminister with aspirin or warfarin
41
Dipyridamole, Cilostazol indication
Prophylaxis for angina
42
Clopidogrel, Ticlopidine description
Platelet aggregation inhibitors | ADP receptor blockers
43
Clopidogrel, Ticlopidine mechanism
Irreversible inhibition of P2Y12 receptor on platelets -> decreased aggregation
44
Clopidogrel, Ticlopidine indication
Recent stroke, MI or acute coronary syndrome Clopidogrel is preferred because is has fewer AE
45
Clopidogrel, Ticlopidine PK
Clopidogrel is a prodrug activated by CYP2C19 ... DO NOT use with omeprazole which inhibits CYP2C19
46
Clopidogrel, Ticlopidine adverse
Inhibits CYP450 Thrombocytopenic purpura Ticlopidine causes neutropenia
47
Aspirin description
inhibits platelet aggregation | COX inhibitor
48
Aspirin mechanism
*Irreversible* acetylation of COX -> blocks TXA2 synthesis -> prolonged bleeding time TXA2 normally increases affinity for GPIIb/IIIa receptor to find fibrinogen
49
Aspirin indication
Cerebral ischemia | Stroke and MI
50
Aspirin PK
No nucleus = no new enzyme for 10 days